Total lymphoid irradiation: New therapeutic option for refractory giant cell myocarditis

Tajinder P. Singh, Raja Rabah, Leslie T Jr. Cooper, Henry L. Walters

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Idiopathic giant cell myocarditis (GCM) is believed to be a T-lymphocyte-mediated autoimmune disease. Some patients with GCM have a dramatic clinical response to anti-T-cell immunosuppression. However, this response is not uniform and patients often deteriorate rapidly and need a cardiac transplantation within months of diagnosis. Following cardiac transplantation, GCM may recur in the graft but is usually mild and responds to augmentation of immunosuppression. This report is the first description of total lymphoid irradiation (TLI) for the treatment of GCM, which was used in a patient who developed an exceptionally early and severe recurrence of GCM in the cardiac graft that remained refractory to heightened immunosuppression for 4 months. Clinical and histologic remission followed a course of TLI and was maintained for 1 year despite a gradual decrease in immunosuppression. This novel treatment should be considered in all patients with GCM who do not have histologic remission with the currently employed anti-T-cell immunosuppression.

Original languageEnglish (US)
Pages (from-to)492-495
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume23
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Lymphatic Irradiation
Myocarditis
Giant Cells
Immunosuppression
Heart Transplantation
T-Lymphocytes
Therapeutics
Transplants
Autoimmune Diseases
Recurrence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Total lymphoid irradiation : New therapeutic option for refractory giant cell myocarditis. / Singh, Tajinder P.; Rabah, Raja; Cooper, Leslie T Jr.; Walters, Henry L.

In: Journal of Heart and Lung Transplantation, Vol. 23, No. 4, 04.2004, p. 492-495.

Research output: Contribution to journalArticle

@article{5f821a08a0a943bc964df5adebc9a5fb,
title = "Total lymphoid irradiation: New therapeutic option for refractory giant cell myocarditis",
abstract = "Idiopathic giant cell myocarditis (GCM) is believed to be a T-lymphocyte-mediated autoimmune disease. Some patients with GCM have a dramatic clinical response to anti-T-cell immunosuppression. However, this response is not uniform and patients often deteriorate rapidly and need a cardiac transplantation within months of diagnosis. Following cardiac transplantation, GCM may recur in the graft but is usually mild and responds to augmentation of immunosuppression. This report is the first description of total lymphoid irradiation (TLI) for the treatment of GCM, which was used in a patient who developed an exceptionally early and severe recurrence of GCM in the cardiac graft that remained refractory to heightened immunosuppression for 4 months. Clinical and histologic remission followed a course of TLI and was maintained for 1 year despite a gradual decrease in immunosuppression. This novel treatment should be considered in all patients with GCM who do not have histologic remission with the currently employed anti-T-cell immunosuppression.",
author = "Singh, {Tajinder P.} and Raja Rabah and Cooper, {Leslie T Jr.} and Walters, {Henry L.}",
year = "2004",
month = "4",
doi = "10.1016/S1053-2498(03)00214-6",
language = "English (US)",
volume = "23",
pages = "492--495",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Total lymphoid irradiation

T2 - New therapeutic option for refractory giant cell myocarditis

AU - Singh, Tajinder P.

AU - Rabah, Raja

AU - Cooper, Leslie T Jr.

AU - Walters, Henry L.

PY - 2004/4

Y1 - 2004/4

N2 - Idiopathic giant cell myocarditis (GCM) is believed to be a T-lymphocyte-mediated autoimmune disease. Some patients with GCM have a dramatic clinical response to anti-T-cell immunosuppression. However, this response is not uniform and patients often deteriorate rapidly and need a cardiac transplantation within months of diagnosis. Following cardiac transplantation, GCM may recur in the graft but is usually mild and responds to augmentation of immunosuppression. This report is the first description of total lymphoid irradiation (TLI) for the treatment of GCM, which was used in a patient who developed an exceptionally early and severe recurrence of GCM in the cardiac graft that remained refractory to heightened immunosuppression for 4 months. Clinical and histologic remission followed a course of TLI and was maintained for 1 year despite a gradual decrease in immunosuppression. This novel treatment should be considered in all patients with GCM who do not have histologic remission with the currently employed anti-T-cell immunosuppression.

AB - Idiopathic giant cell myocarditis (GCM) is believed to be a T-lymphocyte-mediated autoimmune disease. Some patients with GCM have a dramatic clinical response to anti-T-cell immunosuppression. However, this response is not uniform and patients often deteriorate rapidly and need a cardiac transplantation within months of diagnosis. Following cardiac transplantation, GCM may recur in the graft but is usually mild and responds to augmentation of immunosuppression. This report is the first description of total lymphoid irradiation (TLI) for the treatment of GCM, which was used in a patient who developed an exceptionally early and severe recurrence of GCM in the cardiac graft that remained refractory to heightened immunosuppression for 4 months. Clinical and histologic remission followed a course of TLI and was maintained for 1 year despite a gradual decrease in immunosuppression. This novel treatment should be considered in all patients with GCM who do not have histologic remission with the currently employed anti-T-cell immunosuppression.

UR - http://www.scopus.com/inward/record.url?scp=1842529443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842529443&partnerID=8YFLogxK

U2 - 10.1016/S1053-2498(03)00214-6

DO - 10.1016/S1053-2498(03)00214-6

M3 - Article

C2 - 15063411

AN - SCOPUS:1842529443

VL - 23

SP - 492

EP - 495

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 4

ER -